Advances in High Content Screening for Drug Discovery
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2003/08/01
-
Indian UGC (journal)
-
Refrences44
-
Citations121
-
Kenneth A. Giuliano Cellomics, Inc., Pittsburgh, Pennsylvania
-
Jeffrey R. Haskins Cellomics, Inc., Pittsburgh, Pennsylvania
-
D. Lansing Taylor Cellomics, Inc., Pittsburgh, Pennsylvania
Cite
Giuliano, Kenneth A., et al. “Advances in High Content Screening for Drug Discovery”. ASSAY and Drug Development Technologies, vol. 1, no. 4, 2003, pp. 565-77, https://doi.org/10.1089/154065803322302826.
Giuliano, K. A., Haskins, J. R., & Taylor, D. L. (2003). Advances in High Content Screening for Drug Discovery. ASSAY and Drug Development Technologies, 1(4), 565-577. https://doi.org/10.1089/154065803322302826
Giuliano KA, Haskins JR, Taylor DL. Advances in High Content Screening for Drug Discovery. ASSAY and Drug Development Technologies. 2003;1(4):565-77.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Chemistry
Organic chemistry
Biochemistry
You May Also Like
- Peptide therapeutics: current status and future directions
- Exploiting the enhanced permeability and retention effect for tumor targeting
- Natural products in drug discovery
- A new and rapid colorimetric determination of acetylcholinesterase activity
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Cell-Based, High-Content Screen for Receptor Internalization, Recycling and Intracellular Trafficking | BioTechniques |
| 42 | 2000 |
Myosin II transport, organization, and phosphorylation: evidence for cortical flow/solation-contraction coupling during cytokinesis and cell locomotion. | Molecular Biology of the Cell |
| 109 | 1996 |
| 10.1016/S0021-9258(17)30508-2 | Journal of Biological Chemistry |
| 1990 | |
| 10.1016/S0021-9258(19)83641-4 | Journal of Biological Chemistry |
| 1985 | |
| 10.1016/S0021-9258(19)83641-4 | Molecular Cancer Therapeutics |
| 2002 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Droplet microarray platforms for high-throughput drug screening | Microchimica Acta |
| 2 | 2023 |
| The unperturbed picture: Label-free real-time optical monitoring of cells and extracellular vesicles for therapy | Current Opinion in Biomedical Engineering |
| 2022 | |
The impact of microfluidics in high-throughput drug-screening applications | Biomicrofluidics |
| 15 | 2022 |
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus | Virology Journal |
| 1 | 2022 |
| Bioink materials for translational applications | MRS Bulletin |
| 3 | 2022 |
Citations Analysis
The category
Science: Chemistry: Organic chemistry: Biochemistry 41
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Quantum dots and other nanoparticles: what can they offer to drug discovery? and was published in 2004. The most recent citation comes from a 2023 study titled Droplet microarray platforms for high-throughput drug screening. This article reached its peak citation in 2016, with 15 citations. It has been cited in 87 different journals, 14% of which are open access. Among related journals, the ASSAY and Drug Development Technologies cited this research the most, with 10 citations. The chart below illustrates the annual citation trends for this article.